March 11, 2020 / 11:33 AM / a month ago

BRIEF-Spectrum Pharma To Present Data From Phase 2 Clinical Trial For Poziotinib

March 11 (Reuters) - Spectrum Pharmaceuticals Inc:

* SPECTRUM PHARMACEUTICALS TO PRESENT DATA FROM PHASE 2 CLINICAL TRIAL FOR POZIOTINIB AT UPCOMING MEDICAL CONFERENCE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below